Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.750
-0.030 (-1.69%)
Oct 29, 2026, 4:00 PM EDT - Market closed
Longeveron Market Cap
Longeveron has a market cap or net worth of $5.58 million as of October 29, 2026. It is the 44,368th most valuable company in the world and the 5,907th biggest in the United States. Its market cap has decreased by 71.48% in one year.
Market Cap
5.58M
Enterprise Value
-3.92M
1-Year Change
-71.48%
Global Rank
Country Rank
#5,907 United States
Category
ChartMarket Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $5.58M, a decrease of -96.77%. That is a compound annual growth rate of -45.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 5.58M | -48.31% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.98% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 5.96M |
| Acurx Pharmaceuticals | 5.84M |
| Niki BioSolutions | 5.68M |
| XTL Biopharmaceuticals | 5.58M |
| Traws Pharma | 5.49M |
| Pulmatrix | 5.48M |
| Can-Fite BioPharma | 5.22M |
| Xenetic Biosciences | 5.13M |